Home
Conditions
Central Nervous System Infections

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

746 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Completed

Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers

NCT00667602

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Site 22 Bad Kreuznach, Germany

Site 38 Bad Lobenstein, Germany

Site 24 Balve, Germany

Site 3 Berlin, Germany

View all 28 locations

View Trial Details

Completed

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

NCT00874549

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Scottsdale, Arizona, United States

Bardstown, Kentucky, United States

Albuquerque, New Mexico, United States

West Jordon, Utah, United States

View Trial Details

Completed

Arm Cycling to Improve Fitness in Polio Survivors

NCT01271530

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +20 more
Locations: Beaumont Hospital Dublin, Ireland

View Trial Details

Completed

Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects

NCT01519713

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Nagoya, Aichi-ken, Japan

Osaka, Japan

Shinjuku, Tokyo, Japan

View Trial Details

Completed

Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

NCT01856205

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Kanti Children's Hospital Kathmandu, Bagmati, Nepal

BP Koirala Institute of Health Sciences Dharān, Koshi, Nepal

View Trial Details

Completed

Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh

NCT01579825

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: Sylhet, Bangladesh

View Trial Details

Completed

Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan

NCT01389687

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: Fukui-shi, Fukui, Japan

Sapporo, Hokkaido, Japan

View Trial Details

Completed

A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China

NCT01278433

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +11 more
Locations: Beijing, Beijing Municipality, China

Changsha, China

Chengdu, China

Chongqing, China

View all 15 locations

View Trial Details

Completed

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

NCT01491087

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: Guangzhou, Guangdong, China

Shanghai, China

Tianjin, China

View Trial Details

Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants

NCT00303316

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +35 more
Locations: Córdoba, Córdoba Province, Argentina

View Trial Details

Central Nervous System Infections

Central Nervous System Infections trial results

Related conditions